- <![CDATA[Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma ]]><![CDATA[Michael A. Postow, MD, discusses the importance of long-term multidisciplinary follow-up for patients with melanoma treated with ICIs.]]>onclive · 2mo ago↗ source
- <![CDATA[Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanoma]]><![CDATA[Michael A. Postow, MD, discusses the evolving understanding of ICIs in melanoma and the unique toxicity profiles associated with these agents.]]>onclive · 2mo ago↗ source
- FDA chief Marty Makary resigns from agency, ending tumultuous tenure<figure><div><img src="https://imgproxy.divecdn.com/lfiTfXKtJER0ScsazbccJFY15dK3uUIVJZ6JBQZD8TA/g:nowe:0:104/c:1024:578/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy…